Quadrature Capital Ltd increased its stake in The Allstate Co. (NYSE:ALL – Free Report) by 5.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 49,129 shares of the insurance provider’s stock after purchasing an additional 2,612 shares during the quarter. Quadrature Capital Ltd’s holdings in Allstate were worth $8,500,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of the company. Confluence Wealth Services Inc. raised its stake in shares of Allstate by 0.9% in the first quarter. Confluence Wealth Services Inc. now owns 7,547 shares of the insurance provider’s stock valued at $1,306,000 after buying an additional 65 shares during the period. Gradient Investments LLC lifted its holdings in Allstate by 1.6% during the fourth quarter. Gradient Investments LLC now owns 4,130 shares of the insurance provider’s stock valued at $578,000 after purchasing an additional 66 shares during the last quarter. Brighton Jones LLC boosted its position in Allstate by 1.9% during the fourth quarter. Brighton Jones LLC now owns 3,862 shares of the insurance provider’s stock worth $541,000 after purchasing an additional 71 shares during the period. SVB Wealth LLC boosted its position in Allstate by 1.2% during the fourth quarter. SVB Wealth LLC now owns 6,169 shares of the insurance provider’s stock worth $864,000 after purchasing an additional 72 shares during the period. Finally, AdvisorNet Financial Inc raised its position in shares of Allstate by 1.5% in the fourth quarter. AdvisorNet Financial Inc now owns 5,384 shares of the insurance provider’s stock valued at $754,000 after purchasing an additional 82 shares during the period. 76.47% of the stock is owned by institutional investors.
Allstate Price Performance
Shares of NYSE:ALL traded up $3.77 during trading on Friday, reaching $169.17. The company had a trading volume of 1,913,727 shares, compared to its average volume of 1,331,798. The company has a fifty day moving average of $163.94 and a two-hundred day moving average of $163.46. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $44.65 billion, a P/E ratio of 37.34, a price-to-earnings-growth ratio of 1.73 and a beta of 0.48. The Allstate Co. has a 12 month low of $104.29 and a 12 month high of $179.93.
Allstate Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 1st. Stockholders of record on Friday, August 30th will be given a dividend of $0.92 per share. The ex-dividend date of this dividend is Friday, August 30th. This represents a $3.68 annualized dividend and a dividend yield of 2.18%. Allstate’s dividend payout ratio (DPR) is presently 81.24%.
Insiders Place Their Bets
In other news, insider Suren Gupta sold 45,775 shares of the firm’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $177.28, for a total transaction of $8,114,992.00. Following the transaction, the insider now directly owns 89,930 shares of the company’s stock, valued at $15,942,790.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 1.80% of the stock is currently owned by insiders.
Analysts Set New Price Targets
ALL has been the subject of several analyst reports. BMO Capital Markets raised shares of Allstate from a “market perform” rating to an “outperform” rating and raised their price objective for the stock from $190.00 to $191.00 in a report on Thursday, July 18th. Morgan Stanley cut their price target on Allstate from $205.00 to $200.00 and set an “overweight” rating for the company in a report on Wednesday, July 10th. The Goldman Sachs Group boosted their price objective on Allstate from $197.00 to $199.00 and gave the company a “buy” rating in a research note on Friday, July 19th. JPMorgan Chase & Co. raised their target price on Allstate from $193.00 to $200.00 and gave the stock an “overweight” rating in a research note on Thursday, July 11th. Finally, Evercore ISI upped their price target on Allstate from $166.00 to $173.00 and gave the company an “in-line” rating in a research report on Thursday, April 11th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $178.06.
Check Out Our Latest Stock Report on ALL
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories
- Five stocks we like better than Allstate
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Why Call Options Volume for These 2 Stocks Spiked Together
- What are earnings reports?
- MarketBeat Week in Review – 7/22 – 7/26
- 3 Stocks to Consider Buying in October
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.